healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Evidence
parker_2013_rct_radium-223-vs-placebo-alsympca
4 findings
Protocol
medication-cancer-prostate-radium-223-intravenous-four-week-six-cycle
Outcome
oncology-external-beam-radiation-for-bone-pain-time-to-event-measured
n
614
effect
35
attribution
85
Protocol
medication-cancer-prostate-radium-223-intravenous-four-week-six-cycle
Outcome
oncology-spinal-cord-compression-time-to-event-months-measured
n
614
effect
45
attribution
85
Protocol
medication-cancer-prostate-radium-223-intravenous-four-week-six-cycle
Outcome
oncology-symptomatic-skeletal-event-time-to-first-event-months-measured
n
614
effect
40
attribution
85
Protocol
medication-cancer-prostate-radium-223-intravenous-four-week-six-cycle
Outcome
survival-overall-time-months-measured
n
614
effect
35
attribution
85
